This year, as part of the 6th Theranostic World Congress (TWC), June 24-26 2022, Wiesbaden, Germany, the ICPO Foundation proudly launches the
1st Maurits W. Geerlings Next Generation Award for Outstanding Research and Contributions to Actinium-225 related sciences extending to Theranostics.
Maurits Geerlings has pioneered and initiated the supply and research and ultimately the widespread clinical application of the alpha emitter Actinium-225 in Radiomolecular Precision Oncology. The award, bearing his name, honors investigators who have performed groundbreaking work in their research.
The award is endowed with EUR 5,000 and will be presented at the 6th Theranostics World Congress in Wiesbaden, Germany, June 24, 2022 (https://www.twc-2022.org).The winner is invited to deliver a public lecture on their research.
The Award Committee is chaired by Prof. Mike Sathekge, Head of Nuclear Medicine department at University of Pretoria and Steve Biko Academic Hospital.
Eligibility:
- Nominee is a young/mid-career researchers/medical doctors and should have graduated no more than 15 years ago (delay due to childcare shall be mentioned in the cover letter).
- belongs to an academic or public research institution.
- Applicants must exemplify outstanding achievements in preclinical or clinical science concerning applications of alpha emitters for Theranostics.
- The research must include research and contributions to Actinium-225 related sciences extending to Theranostics in the following areas: radiochemistry, radiopharmacology, medical physics, internal and external dosimetry, new radioisotopes, radiobiology, clinical translation, clinical studies, etc.
- Nominee has successfully been mentoring graduate students, postdocs, clinical staff members, visiting scientists, peers, etc.
Application Procedure:
The application documents should include:
- Cover letter describing own impact in the field of Theranostics (max. 3 pages, incl. graphics and bibliography related to Actinium-225 radiopharmaceuticals.
- CV including publication list (or as separate document).
- 1 to max. 3 additional letters of recommendation.
- Publication in the last 2 years (published in a peer-reviewed journal or submitted and accepted with written proof) in the field of Actinium-225 related sciences extending to Theranostics.
The application documents should be submitted no later than April 30, 2022 (23:59 CET). The successful applicant will be informed by email until May 16, 2022.
Please send your application to mg-nga@icpo.foundation or use the following form: